Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of 1.12 trillion as of October 10, 2025. Its market cap has increased by 63.04% in one year.

Market Cap

1.12T

Enterprise Value

1.12T

Revenue

46.43B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,380.00

Market Cap Chart

Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 1.32B to 1.12T, an increase of 84,519.71%. That is a compound annual growth rate of 37.06%.

Market Cap History

Date	Market Cap	% Change
Oct 10, 2025	1,119.35B	76.99%
Dec 31, 2024	632.43B	55.74%
Dec 29, 2023	406.09B	-28.80%
Dec 30, 2022	570.31B	37.16%
Dec 31, 2021	415.79B	38.38%
Dec 31, 2020	300.47B	24.07%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Wal-Mart de México	946.81B
Grupo Financiero Banorte	492.95B
Industrias Peñoles	316.90B
Arca Continental	310.08B
GMéxico Transportes	155.40B
FIBRA Prologis	119.60B
Fibra UNO	104.68B
Promotora y Operadora de Infraestructura, S. A. B. de C. V.	98.85B

Market Cap Rankings